CS logo
small CS logo
AD-CARE, University of Rochester Medical Center

Rochester, New York, United States
University in Rochester, New York
601 Elmwood Ave, Rochester, NY 14642

About AD-CARE, University of Rochester Medical Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Athira Pharma
2
Genentech, Inc.
2
National Institute on Aging (NIA)
2
Pfizer
1
Total Rows: 5

Clinical Trials at AD-CARE, University of Rochester Medical Center


During the past decade, AD-CARE, University of Rochester Medical Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11111122220000000000Started TrialsCompleted Trails201720182019202020210123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)
2002-07-01
2005-06-01
Completed
60
VITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study)
2003-01-01
2007-06-01
Completed
340
Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients
2008-06-01
2013-08-01
Terminated
901
A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease
2017-10-04
2021-01-15
Terminated
457
Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
2018-08-22
2022-11-28
Terminated
982
A Study of Semorinemab in Patients With Moderate Alzheimer's Disease
2019-01-30
2023-08-23
Active, not recruiting
272
A Study To Evaluate The Efficacy And Safety Of Obinutuzumab In Patients With ISN/RPS 2003 Class III Or IV Lupus Nephritis
2020-08-10
2028-02-12
Recruiting
252
A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD)
2021-02-01
2023-03-06
Terminated
1,379

Rows per page:

1–10 of 10

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "AD-CARE, University of Rochester Medical Center" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Athira Pharma" with 2 trials sponsored, "Genentech, Inc." with 2 trials sponsored, "National Institute on Aging (NIA)" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "AD-CARE, University of Rochester Medical Center" #1 collaborator was "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 3Hoffmann-La Roche: 3Athira Pharma: 2Athira Pharma: 2Genentech, Inc.: 2Genentech, Inc.: 2National Institute onAging (NIA): 2National Institute onAging (NIA): 2Pfizer: 1Pfizer: 1

Created with Highcharts 11.1.0Top CollaboratorsAlzheimer's DiseaseCooperative Study(ADCS): 1Alzheimer's DiseaseCooperative Study(ADCS): 1

Clinical Trials Conditions at AD-CARE, University of Rochester Medical Center


According to Clinical.Site data, the most researched conditions in "AD-CARE, University of Rochester Medical Center" are "Alzheimer Disease" (5 trials), "Alzheimer's Disease" (3 trials), "Dementia" (1 trials), "Dementia of Alzheimer Type" (1 trials) and "Lupus Nephritis" (1 trials). Many other conditions were trialed in "AD-CARE, University of Rochester Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at AD-CARE, University of Rochester Medical Center


Most popular intervention types in "AD-CARE, University of Rochester Medical Center" are "Drug" (10 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "ATH-1017" (2 trials), "Gantenerumab" (2 trials), "Semorinemab" (2 trials) and "[18F]GTP1" (2 trials). Other intervention names were less common.

Clinical Trials Genders at AD-CARE, University of Rochester Medical Center


The vast majority of trials in "AD-CARE, University of Rochester Medical Center" are 10 trials for "All" genders.

Clinical Trials Status at AD-CARE, University of Rochester Medical Center


Currently, there are NaN active trials in "AD-CARE, University of Rochester Medical Center". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in AD-CARE, University of Rochester Medical Center, undefined suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in AD-CARE, University of Rochester Medical Center, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 7Phase 3: 7Phase 2: 4Phase 2: 4Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusTerminated: 4Terminated: 4Completed: 2Completed: 2Recruiting: 2Recruiting: 2Active, not recruiting: 1Active, not recruiting: 1Enrolling by invitation: 1Enrolling by invitation: 1